Back to Search
ROBIN SCHIFF, MD
MD
Pediatric Adolescent Medicine Physician
NPI: 1881903136Individual
Specialties, Licenses & Credentials
Pediatric Adolescent Medicine PhysicianPrimary
Pediatrics — Adolescent Medicine
Code: 2080A0000X
203482(NY)
Research & Publications (20)
Advance end-of-life healthcare planning in an acute NHS hospital setting; development and evaluation of the Expression of Healthcare Preferences (EHP) document.
PMID 19029089·Age Ageing·2009
8-other
Molecular profiles of progesterone receptor loss in human breast tumors.
PMID 18425577·Breast Cancer Res Treat·2009
4-observational
Spinal cord dysmyelination caused by an antiproteolipid protein IgM antibody: implications for the mechanism of central nervous system myelin formation.
PMID 18951490·J Neurosci Res·2009
7-preclinical
Irbesartan improves arterial compliance more than lisinopril.
PMID 19649309·Vasc Health Risk Manag·2009
4-observational
Spongiform pathology in mouse CNS lacking 'neuropathy target esterase' and cellular prion protein.
PMID 19524041·Neurobiol Dis·2009
7-preclinical
18-Month study of intravenous immunoglobulin for treatment of mild Alzheimer disease.
PMID 18294736·Neurobiol Aging·2009
3-trial
Post-transcriptional regulation of chemokine receptor CXCR4 by estrogen in HER2 overexpressing, estrogen receptor-positive breast cancer cells.
PMID 18807177·Breast Cancer Res Treat·2009
8-other
Imaging biomarkers predict response to anti-HER2 (ErbB2) therapy in preclinical models of breast cancer.
PMID 19584166·Clin Cancer Res·2009
7-preclinical
Effects of osmolality on PLP-null myelin structure: implications re axon damage.
PMID 19094971·Brain Res·2009
7-preclinical
Crosstalk between the estrogen receptor and the HER tyrosine kinase receptor family: molecular mechanism and clinical implications for endocrine therapy resistance.
PMID 18216219·Endocr Rev·2008
6-review
Tamoxifen resistance in breast tumors is driven by growth factor receptor signaling with repression of classic estrogen receptor genomic function.
PMID 18245484·Cancer Res·2008
7-preclinical
Development of resistance to targeted therapies transforms the clinically associated molecular profile subtype of breast tumor xenografts.
PMID 18794137·Cancer Res·2008
7-preclinical
Proteomic analysis of tumor necrosis factor-alpha resistant human breast cancer cells reveals a MEK5/Erk5-mediated epithelial-mesenchymal transition phenotype.
PMID 19087274·Breast Cancer Res·2008
8-other
Dual roles for coactivator activator and its counterbalancing isoform coactivator modulator in human kidney cell tumorigenesis.
PMID 18829545·Cancer Res·2008
7-preclinical
Treatment of human epidermal growth factor receptor 2-overexpressing breast cancer xenografts with multiagent HER-targeted therapy.
PMID 17470737·J Natl Cancer Inst·2007
7-preclinical
Deficient morphological processing in adults with developmental dyslexia: another barrier to efficient word recognition?
PMID 17557687·Dyslexia·2007
8-other
Dual-labeled trastuzumab-based imaging agent for the detection of human epidermal growth factor receptor 2 overexpression in breast cancer.
PMID 17785729·J Nucl Med·2007
7-preclinical
Complexity oi treatment decisions with older patients: who, when and what to treat?
PMID 17990722·Clin Med (Lond)·2007
5-case
The dynamics of estrogen receptor status in breast cancer: re-shaping the paradigm.
PMID 18056165·Clin Cancer Res·2007
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2711 HENRY HUDSON PKWY, 1F
BRONX, NY 10463 - Phone
- (718) 549-6229
Quick Facts
- NPI
- 1881903136
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile